宫颈癌筛查中人乳头状瘤病毒检测现状  

The status of human papilloma virus test in cervical cancer screening

作　　者：高维娇[1] 高雨农[1] Gao Weijiao;Gao Yunong(Department of Gynecologic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China)

机构地区：[1]北京大学肿瘤医院暨北京市肿瘤防治研究所妇瘤科,北京100142

出　　处：《肿瘤综合治疗电子杂志》2021年第3期47-50,共4页Journal of Multidisciplinary Cancer Management(Electronic Version)

摘　　要：随着对高危型人乳头状瘤病毒(human papilloma virus,HPV)与宫颈癌之间关系研究的深入,以及HPV检测技术的进步,宫颈癌筛查策略也在不断发展和变化。尽管宫颈细胞学检查仍然是目前世界范围内最常用和最重要的宫颈癌筛查手段之一,但HPV检测在宫颈癌筛查中的意义和地位日益重要。The cervical cancer screening strategy is constantly changing with the technological development of human papilloma virus(HPV)test and research on the relationship between high-risk HPV and cervical cancer.Although cytological examination is still one of the most commonly used and important screening methods for cervical cancer in the world,but the role of HPV test in cervical cancer screening has become increasingly important.

关 键 词：人乳头状瘤病毒 宫颈癌 筛查 

分 类 号：R737.33[医药卫生—肿瘤]